Up-Regulated Tissue Factor Expression in Antiphospholipid Syndrome

• References

• 1 Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341-344
• 2 Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Suzuki T, Yoshida S, Koike T. Heterogeneity of anticardiolipin antibodies defined by the anti-cardiolipin cofactor. J Immunol 1992; 148: 3885-3891
• 3 Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other “antiphospholipid” antibodies. Blood 1994; 84: 2854-2867
• 4 Simantov R, LaSala JM, Lo SK, Gharavi AE, Sammaritano LR, Salmon JE, Silverstein RL. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 1995; 96: 2211-2219
• 5 Amout J. The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thromb Haemost 1996; 75: 536-541
• 6 Nemerson Y. Tissue factor and hemostasis. Blood 1988; 71: 1-8
• 7 Tannenbaum SH, Finco R, Cines DB. Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol 1986; 137: 1532-1537
• 8 Albrecht S, Kotzsch M, Siegert G, Luther T, Groβmann H, Groβer M, Müller M. Detection of circulating tissue factor and factor VII in a normal population. Thromb Haemost 1996; 75: 772-777
• 9 Wada H, Nakase T, Nakaya R, Minamikawa K, Wakita Y, Kaneko T, Ohiwa M, Deguchi K, Shirakawa S. Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation. Am J Hematol 1994; 45: 232-236